[HTML][HTML] COVID-19 vaccination and cardiac dysfunction
W Leowattana, T Leowattana - World Journal of Cardiology, 2022 - ncbi.nlm.nih.gov
Abstract The coronavirus disease 2019 (COVID-19) mRNA vaccine against severe acute
respiratory syndrome coronavirus 2 infections has reduced the number of symptomatic …
respiratory syndrome coronavirus 2 infections has reduced the number of symptomatic …
COVID-19 vaccination and cardiac dysfunction
W Leowattana, T Leowattana - World Journal of …, 2022 - mahidol.elsevierpure.com
Abstract The coronavirus disease 2019 (COVID-19) mRNA vaccine against severe acute
respiratory syndrome coronavirus 2 infections has reduced the number of symptomatic …
respiratory syndrome coronavirus 2 infections has reduced the number of symptomatic …
[引用][C] COVID-19 vaccination and cardiac dysfunction
W Leowattana, T Leowattana - World Journal of Cardiology, 2022 - cir.nii.ac.jp
COVID-19 vaccination and cardiac dysfunction | CiNii Research CiNii 国立情報学研究所 学術
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
情報ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
COVID-19 vaccination and cardiac dysfunction
W Leowattana, T Leowattana - World journal of …, 2022 - pubmed.ncbi.nlm.nih.gov
The coronavirus disease 2019 (COVID-19) mRNA vaccine against severe acute respiratory
syndrome coronavirus 2 infections has reduced the number of symptomatic patients …
syndrome coronavirus 2 infections has reduced the number of symptomatic patients …
[PDF][PDF] WJC
W Leowattana, T Leowattana - World, 2022 - pdfs.semanticscholar.org
Abstract The coronavirus disease 2019 (COVID-19) mRNA vaccine against severe acute
respiratory syndrome coronavirus 2 infections has reduced the number of symptomatic …
respiratory syndrome coronavirus 2 infections has reduced the number of symptomatic …
[PDF][PDF] WJC
W Leowattana, T Leowattana - World, 2022 - scienceopen.com
Abstract The coronavirus disease 2019 (COVID-19) mRNA vaccine against severe acute
respiratory syndrome coronavirus 2 infections has reduced the number of symptomatic …
respiratory syndrome coronavirus 2 infections has reduced the number of symptomatic …
COVID-19 vaccination and cardiac dysfunction
W Leowattana, T Leowattana - 2022 - ir.swu.ac.th
The coronavirus disease 2019 (COVID-19) mRNA vaccine against severe acute respiratory
syndrome coronavirus 2 infections has reduced the number of symptomatic patients …
syndrome coronavirus 2 infections has reduced the number of symptomatic patients …
COVID-19 vaccination and cardiac dysfunction.
W Leowattana, T Leowattana - World Journal of Cardiology, 2022 - europepmc.org
Abstract The coronavirus disease 2019 (COVID-19) mRNA vaccine against severe acute
respiratory syndrome coronavirus 2 infections has reduced the number of symptomatic …
respiratory syndrome coronavirus 2 infections has reduced the number of symptomatic …